Cardinal Third Party Logistics Pharmaceutical Import Profile — United States (DGFT 2022–2026)

Name: Cardinal Third Party Logistics Pharmaceutical Import Records from India — 3 Products, $2.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Cardinal Third Party Logistics — Pharmaceutical Importer Profile (2026) | 3 Products, $2.8M Trade | TransData Nexus

Cardinal Third Party Logistics

Pharmaceutical Importer · United States · Vitamins & Supplements Focus · $2.8M Total Trade · DGFT Verified

Cardinal Third Party Logistics is a pharmaceutical importer based in United States with a total trade value of $2.8M across 3 products in 2 therapeutic categories. Based on 56 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Cardinal Third Party Logistics sources from 2 verified Indian suppliers, with Gland Pharma Limited accounting for 87.2% of imports.

Cardinal Third Party Logistics — Import Portfolio & Supplier Network

Cardinal Third Party Logistics import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Cardinal Third Party Logistics?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Gland Pharma Limited	$6.6M	156	87.2%
Astral Steritech Private Limited	$965.6K	21	12.8%

Cardinal Third Party Logistics sources from 2 verified Indian suppliers across .

What Formulations Does Cardinal Third Party Logistics Import?

Formulation	Value	Ships
Ampicillin and sulbactam sodium for	$575.9K	13
Dexmedetomidine hydrochloride injection200mcg/2ML (100mcg/ML), 2ML fill in	$390.1K	9
Dexmedetomidine hydrochloride	$350.0K	7
Zinc sulfate injection USP 25MG/5ML 5MG/ML of	$300.0K	6
Glycopyrrolate injection USP 4MG/20ML	$250.1K	6
Doxycycline for injection USP 100 MG/vial, 20ML	$250.0K	5
Dexmedetomidine hydrochloride in 0.9 percent sodium chloride injection 4mcg/ML,100ML fill in 100ML	$216.0K	5
Succinylcholine chloride injection 200MG/10ML (20MG/ML),10ML fill in a	$203.0K	8
Doxycycline for injection USP 100MG/vial, 20ML	$200.0K	4
Succinylcholine chloride injection 200MG/10 ML (20MG/ML),10ML fill in a	$200.0K	4
Succinylcholine chloride injection 200MG 10 ML 20MG ML 10ML fill in a	$200.0K	4
Zinc sulfate injection USP 25MG/5ML (5MG/ML) of	$193.8K	4
Glycopyrrolate injection USP 0.2MG/ML,1ML fill in 2ML	$158.1K	4
Ampicillin & sulbactam for injection	$150.0K	3
Dexmedetomidine hydrochloride injection200mcg/2ML (100mcg/ML), 2ML fill in 2mlvial Each ML	$150.0K	3

Cardinal Third Party Logistics imports 68 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Zinc	Vitamins & Supplements	$1.4M	29	1.8%	5
2	Doxycycline	Antibiotics	$800.0K	16	0.7%	10
3	Ampicillin	Antibiotics	$550.0K	11	0.4%	9

Cardinal Third Party Logistics imports 3 pharmaceutical products across 2 categories into United States totaling $2.8M.

Cardinal Third Party Logistics — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Cardinal Third Party Logistics is a U.S.-based pharmaceutical importer specializing in the acquisition of finished pharmaceutical formulations from India. Operating as a third-party logistics provider (3PL), the company focuses on sourcing and importing pharmaceutical products to meet the demands of the U.S. market. Headquartered in La Vergne, Tennessee, Cardinal Third Party Logistics plays a pivotal role in the U.S. pharmaceutical distribution network by facilitating the importation of essential medications.

The company imports a diverse range of pharmaceutical products, including tablets, capsules, syrups, and injections, sourced from Indian manufacturers. This strategic sourcing enables Cardinal Third Party Logistics to offer a variety of medications to the U.S. market, contributing to the availability of essential drugs. By leveraging its expertise in logistics and supply chain management, the company ensures the efficient and compliant importation of pharmaceutical products, thereby supporting the U.S. healthcare system.

2Distribution Network

Cardinal Third Party Logistics operates a comprehensive distribution network within the United States, with its primary facility located in La Vergne, Tennessee. This central location facilitates efficient transportation and distribution of imported pharmaceutical products across the country. The company's logistics capabilities include warehousing, inventory management, and transportation services, ensuring timely and secure delivery of medications to various stakeholders in the healthcare sector.

While the company's distribution network is primarily focused within the United States, its strategic partnerships with Indian pharmaceutical manufacturers enable it to source a wide array of products. This international collaboration enhances the company's ability to meet the diverse needs of the U.S. pharmaceutical market, ensuring a steady supply of essential medications.

3Industry Role

In the U.S. pharmaceutical supply chain, Cardinal Third Party Logistics functions as a pharmaceutical importer and logistics intermediary. By sourcing finished pharmaceutical formulations from Indian manufacturers, the company bridges the gap between international production and domestic distribution. This role is crucial in ensuring the availability of a diverse range of medications in the U.S. market, particularly those that may not be produced domestically.

The company's operations support various segments of the U.S. healthcare system, including retail pharmacies, hospitals, and clinics, by providing access to a broad spectrum of pharmaceutical products. Through its efficient logistics and supply chain management, Cardinal Third Party Logistics contributes to the overall resilience and responsiveness of the U.S. pharmaceutical supply chain.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Cardinal Third Party Logistics

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Cardinal Third Party Logistics demonstrates a high degree of supplier concentration, sourcing 87.2% of its imported pharmaceutical products from GLAND PHARMA LIMITED and 12.8% from ASTRAL STERITECH PRIVATE LIMITED. This concentrated sourcing strategy may present risks related to supply chain disruptions, such as production delays or quality control issues.

However, the company's consistent importation of 56 shipments over a period from December 2017 to January 2024 indicates a stable and ongoing relationship with these suppliers. This stability suggests that Cardinal Third Party Logistics has established effective risk mitigation strategies, such as maintaining safety stock levels and diversifying its supplier base, to ensure a continuous supply of pharmaceutical products.

2Supply Chain Resilience

The resilience of Cardinal Third Party Logistics's supply chain is influenced by its reliance on two primary Indian suppliers: GLAND PHARMA LIMITED and ASTRAL STERITECH PRIVATE LIMITED. While this focused sourcing approach may streamline operations, it also exposes the company to potential risks associated with supplier-specific disruptions, including production delays, quality control issues, or geopolitical factors affecting trade.

To enhance supply chain resilience, Cardinal Third Party Logistics could consider diversifying its supplier base by engaging with additional Indian pharmaceutical manufacturers. This strategy would mitigate risks associated with over-reliance on a limited number of suppliers and ensure a more robust and adaptable supply chain capable of meeting the dynamic demands of the U.S. pharmaceutical market.

Importing Pharmaceuticals into United States — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for United States

1Regulatory Authority & Framework

In the United States, the Food and Drug Administration (FDA) serves as the primary regulatory authority overseeing the importation of pharmaceutical products. The FDA enforces the Federal Food, Drug, and Cosmetic Act (FD&C Act), which sets forth requirements for the safety, efficacy, and quality of drugs imported into the U.S. Pharmaceutical importers must ensure that their products comply with FDA regulations, including proper labeling, manufacturing practices, and approval status.

For Indian pharmaceutical manufacturers, obtaining FDA approval for their products is essential for legal importation into the U.S. market. This process involves submitting a New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) to demonstrate that the product meets FDA standards. Additionally, foreign drug establishments must register with the FDA and list all their drug products intended for U.S. distribution. Compliance with these regulatory requirements is crucial for maintaining the integrity and safety of the U.S. pharmaceutical supply chain.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products entering the United States are governed by the FDA. Importers must file an entry notice and an entry bond with U.S. Customs and Border Protection, notifying the FDA of the product's arrival. The FDA then reviews the shipment to determine its admissibility based on compliance with U.S. regulations. If a product is found to be adulterated, misbranded, or unapproved, it may be refused entry into the U.S. market.

Cardinal Third Party Logistics — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Cardinal Third Party Logistics's focus on importing finished pharmaceutical formulations, particularly in the categories of Vitamins & Supplements and Antibiotics, aligns with market demand for these essential products. The significant import value in these categories indicates a strong market need and suggests that the company is strategically positioning itself to meet consumer health requirements.

The importation of these products also reflects the company's commitment to providing a diverse range of medications to the U.S. market, ensuring that consumers have access to both preventive and therapeutic options. By sourcing these products from reputable Indian manufacturers, Cardinal Third Party Logistics contributes to the availability of high-quality pharmaceutical options in the U.S. market.

2Sourcing Profile

Cardinal Third Party Logistics's sourcing strategy emphasizes the importation of generic pharmaceutical products, primarily in the form of tablets, capsules, syrups, and injections. This approach allows the company to offer cost-effective alternatives to brand-name medications, catering to a broad consumer base seeking affordable healthcare options.

India's well-established pharmaceutical manufacturing industry, known for its adherence to international quality standards, makes it an attractive sourcing destination for Cardinal Third Party Logistics. By partnering with Indian manufacturers, the company can leverage competitive pricing and a diverse product portfolio, enhancing its ability to meet the varied needs of the U.S. pharmaceutical market.

Frequently Asked Questions — Cardinal Third Party Logistics

What products does Cardinal Third Party Logistics import from India?

Cardinal Third Party Logistics imports 3 pharmaceutical products across 2 categories. Top imports: Zinc ($1.4M), Doxycycline ($800.0K), Ampicillin ($550.0K).

Who supplies pharmaceuticals to Cardinal Third Party Logistics from India?

Cardinal Third Party Logistics sources from 2 verified Indian suppliers. The primary supplier is Gland Pharma Limited (87.2% of imports, $6.6M).

What is Cardinal Third Party Logistics's total pharmaceutical import value?

Cardinal Third Party Logistics's total pharmaceutical import value from India is $2.8M, based on 56 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Cardinal Third Party Logistics focus on?

Cardinal Third Party Logistics imports across 2 categories. The largest: Vitamins & Supplements (51.8%), Antibiotics (48.2%).

Get Full Cardinal Third Party Logistics Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Cardinal Third Party Logistics

Cardinal Third Party Logistics — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Cardinal Third Party Logistics?

What Formulations Does Cardinal Third Party Logistics Import?

What Products Does Cardinal Third Party Logistics Import?

Top Products by Import Value

Cardinal Third Party Logistics Therapeutic Categories — 2 Specializations